We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

166 hedge funds and large institutions have $735M invested in Natus Medical Inc in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 65 increasing their positions, 53 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 53

3% less funds holding

Funds holding: 172166 (-6)

16% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 25

29% less capital invested

Capital invested by funds: $1.04B → $735M (-$300M)

63% less call options, than puts

Call options by funds: $1.85M | Put options by funds: $4.99M

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
166
Holders Change
-6
Holders Change %
-3.49%
% of All Funds
3.66%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
21
Increased
65
Reduced
53
Closed
25
Calls
$1.85M
Puts
$4.99M
Net Calls
-$3.13M
Net Calls Change
-$3.68M
Name Holding Trade Value Shares
Change
Change in
Stake
Arrowstreet Capital
26
Arrowstreet Capital
Massachusetts
$7.57M +$2.79M +95,915 +41%
Ameriprise
27
Ameriprise
Minnesota
$7.01M -$1.85M -63,784 -17%
Principal Financial Group
28
Principal Financial Group
Iowa
$6.44M -$302K -10,401 -4%
Diamond Hill Capital Management
29
Diamond Hill Capital Management
Ohio
$6.29M -$2.94M -101,214 -27%
Invesco
30
Invesco
Georgia
$5.1M -$836K -28,768 -12%
RCM
31
Rutabaga Capital Management
Massachusetts
$4.69M +$190K +6,550 +3%
MAM
32
Martingale Asset Management
Massachusetts
$4.23M +$186K +6,400 +4%
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$3.65M +$3.22M +110,725 +236%
CIM
34
Confluence Investment Management
Missouri
$3.59M -$97.9K -3,367 -2%
BCC
35
Bridge City Capital
Oregon
$3.3M +$526K +18,087 +15%
SI
36
Sapience Investments
California
$3.19M -$1.14M -39,175 -22%
SO
37
STRS Ohio
Ohio
$3.12M -$846K -29,100 -18%
Simplex Trading
38
Simplex Trading
Illinois
$3.11M +$3.83M +131,844 +5,152%
Bank of America
39
Bank of America
North Carolina
$2.79M +$9.39K +323 +0.3%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$2.55M +$59K +2,031 +2%
Deutsche Bank
41
Deutsche Bank
Germany
$2.54M -$185K -6,352 -5%
Citadel Advisors
42
Citadel Advisors
Florida
$2.46M +$2.09M +72,035 +209%
PCM
43
Polaris Capital Management
Massachusetts
$2.42M +$625K +21,500 +26%
Acadian Asset Management
44
Acadian Asset Management
Massachusetts
$2.3M +$2.08M +71,549 +256%
WC
45
Walthausen & Co
New York
$2.3M -$69.8K -2,400 -2%
Legal & General Group
46
Legal & General Group
United Kingdom
$2.27M +$39.7K +1,367 +1%
Morgan Stanley
47
Morgan Stanley
New York
$2.22M -$2.09M -71,756 -43%
Bessemer Group
48
Bessemer Group
New Jersey
$2.19M +$63.9K +2,200 +2%
PPA
49
Parametric Portfolio Associates
Washington
$1.88M -$524K -18,036 -18%
QI
50
QS Investors
New York
$1.86M

NTUS Hedge Fund Activity: Q1 2020 in Review

166 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q1 2020, worth a combined $735M — down 29% from $1.04B a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of NTUS and 21 opened new positions — a net loss of 4 holders — while 53 trimmed existing stakes and 65 added.

The largest buyer was Victory Capital Management, adding an estimated $39M. The largest seller was Janus Henderson Group, cutting an estimated $17.6M.

  • 166 institutional investors held Natus Medical Inc (NTUS) as of Q1 2020, down from 172 in Q4 2019.
  • Funds reported $735M of Natus Medical Inc stock for Q1 2020, down 29% quarter-over-quarter.
  • 21 funds opened new Natus Medical Inc positions in Q1 2020 and 25 closed out, a net change of -4 holders.
  • The largest Natus Medical Inc buyer in Q1 2020 was Victory Capital Management, an estimated $39M added.
  • The largest Natus Medical Inc seller in Q1 2020 was Janus Henderson Group, an estimated $17.6M sold.

Based on aggregated 13F filings for Q1 2020.